A review of cardiovascular risks associated with medications used to treat type-2 diabetes mellitus.
作者信息
St Onge Erin L, Motycka Carol Anne, Miller Shannon A
出版信息
P T. 2009 Jul;34(7):368-78.
Abstract
摘要
相似文献
1
2
Cardiovascular risks and benefits with oral drugs for Type 2 diabetes mellitus.口服药物治疗 2 型糖尿病的心血管风险与获益。
Expert Rev Clin Pharmacol. 2014 Mar;7(2):225-33. doi: 10.1586/17512433.2014.885836. Epub 2014 Feb 4.
3
Cardiovascular Risks and Benefits of Medications Used for Weight Loss.用于减肥的药物的心血管风险与益处。
Front Endocrinol (Lausanne). 2020 Jan 15;10:883. doi: 10.3389/fendo.2019.00883. eCollection 2019.
4
Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study.瑞典2型糖尿病患者降脂药物的续方依从性与心血管疾病风险及死亡率之间的关联：一项全国性队列研究
BMJ Open. 2018 Mar 30;8(3):e020309. doi: 10.1136/bmjopen-2017-020309.
5
Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.用于治疗2型糖尿病的非胰岛素药物的心血管益处及安全性。
Postgrad Med. 2017 Nov;129(8):811-821. doi: 10.1080/00325481.2017.1358064. Epub 2017 Jul 27.
6
A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data.对 FDA 批准的糖尿病药物标签的全面回顾：适应证、安全性和新兴的心血管安全性数据。
J Diabetes Complications. 2017 Dec;31(12):1719-1727. doi: 10.1016/j.jdiacomp.2017.08.005. Epub 2017 Aug 12.
7
Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus: a systematic review.评价 2 型糖尿病口服药物治疗指南推荐：系统评价。
Ann Intern Med. 2012 Jan 3;156(1 Pt 1):27-36. doi: 10.7326/0003-4819-156-1-201201030-00005.
8
Risk of cardiovascular event and mortality in relation to refill and guideline adherence to lipid-lowering medications among patients with type 2 diabetes mellitus in Sweden.在瑞典，2 型糖尿病患者的心血管事件和死亡率与降脂药物的续药和指南依从性相关。
BMJ Open Diabetes Res Care. 2019 Apr 8;7(1):e000639. doi: 10.1136/bmjdrc-2018-000639. eCollection 2019.
9
Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians.2型糖尿病的药物降脂治疗：美国医师协会背景文件
Ann Intern Med. 2004 Apr 20;140(8):650-8. doi: 10.7326/0003-4819-140-8-200404200-00013.
10
Pharmacological Prevention of Cardiovascular Outcomes in Diabetes Mellitus: Established and Emerging Agents.糖尿病患者的心血管结局的药物预防：已确立和新兴的药物。
Drugs. 2018 Feb;78(2):203-214. doi: 10.1007/s40265-017-0857-3.
引用本文的文献
1
Temporal Trend of the Prevalence of Modifiable Risk Factors of Stroke: An Ecological Study of Brazilians between 2006 and 2012.中风可改变风险因素患病率的时间趋势：一项针对2006年至2012年间巴西人的生态学研究。
Int J Environ Res Public Health. 2022 May 6;19(9):5651. doi: 10.3390/ijerph19095651.
2
Athero-protective actions of two oral antidiabetic drugs: Suppression of inflammation and oxidative stress.两种口服抗糖尿病药物的抗动脉粥样硬化作用：抑制炎症和氧化应激。
J Cardiovasc Dis Res. 2012 Jan;3(1):3-4. doi: 10.1016/s0975-3583(12)31002-4.
本文引用的文献
1
Glucose control and vascular complications in veterans with type 2 diabetes.2型糖尿病退伍军人的血糖控制与血管并发症
N Engl J Med. 2009 Jan 8;360(2):129-39. doi: 10.1056/NEJMoa0808431. Epub 2008 Dec 17.
2
Effects of intensive glucose lowering in type 2 diabetes.强化降糖对2型糖尿病的影响。
N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6.
3
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.2型糖尿病患者强化血糖控制与血管转归
N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6.
4
Cardiovascular disease in diabetes.糖尿病中的心血管疾病
Diabetes Care. 2008 Jun;31(6):1260-6. doi: 10.2337/dc08-zb06.
5
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies.2型糖尿病中的心血管疾病风险：机制研究的见解
Lancet. 2008 May 24;371(9626):1800-9. doi: 10.1016/S0140-6736(08)60768-0.
6
Diabetic myocardial disease: pathophysiology, early diagnosis and therapeutic options.糖尿病性心肌病：病理生理学、早期诊断及治疗选择
J Diabetes Complications. 2009 Jul-Aug;23(4):273-82. doi: 10.1016/j.jdiacomp.2007.12.005. Epub 2008 Apr 16.
7
Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial.吡格列酮与格列美脲对2型糖尿病患者冠状动脉粥样硬化进展的比较：PERISCOPE随机对照试验
JAMA. 2008 Apr 2;299(13):1561-73. doi: 10.1001/jama.299.13.1561. Epub 2008 Mar 31.
8
Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities.优化2型糖尿病合并心血管疾病患者的抗糖尿病治疗方案。
Pharmacotherapy. 2008 Feb;28(2):193-206. doi: 10.1592/phco.28.2.193.
9
Type 2 diabetes mellitus and heart failure.2型糖尿病与心力衰竭
Pharmacotherapy. 2008 Feb;28(2):170-92. doi: 10.1592/phco.28.2.170.
10
Thiazolidinediones and cardiovascular outcomes in older patients with diabetes.噻唑烷二酮类药物与老年糖尿病患者的心血管结局
JAMA. 2007 Dec 12;298(22):2634-43. doi: 10.1001/jama.298.22.2634.
Zotero 插件